Last 12 months
Inside the activity.
5 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 2 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 1 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 24, 2017 Filed Jul 25, 2017 19:26 UTC |
KERSTEN GEERT RDirector · Chief Executive Officer
|
GrantConvertible Note · Derivative | 109,170 | $250,000.00 Strike: $2.29 | $27,292,500,000.00 |
DisclosureSEC source: 0001236031-17-000010 · primary_doc.xml · derivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Beneficiary Disclosed balance after: 688,441 Underlying: Common Stock · 109,170 shares Expires 2017-12-22 F1 · ownership.direct: A trust in which Mr. Kersten holds a beneficial interest participated in an offering and purchased a note in the principal amount of $250,000 as well the Series NN warrant. Shares issuable upon the conversion of the notes or exercise of the warrant will be restricted securities unless registered. The number of securities beneficially owned gives effect to the 25-for-1 reverse stock split which became effective on June 15, 2017, and include Series N warrants (as amended) to purchase 85,339 shares of common stock held by the de Clara Trust. The amended Series N warrants expire on August 18, 2018 and are exercisable at a price of $3.00 per share. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 14:39 UTC |
ZIMMERMAN DANIEL HSr. Vice President
|
GrantCommon Stock | 1,532 | $2.23 | $3,416.36 |
DisclosureSEC source: 0001236215-17-000009 · primary_doc.xml · nonDerivative · entry 1 ZIMMERMAN DANIEL H · CIK 0001236028 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,693 Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 14:21 UTC |
TALOR EYALChief Scientific Officer
|
GrantCommon Stock | 1,076 | $2.23 | $2,399.48 |
DisclosureSEC source: 0001236215-17-000008 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,331 Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 14:12 UTC |
KERSTEN GEERT RDirector · Chief Executive Officer
|
GrantCommon Stock | 1,782 | $2.23 | $3,973.86 |
DisclosureSEC source: 0001236215-17-000006 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 482,842 Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 14:07 UTC |
PRICHEP PATRICIA BSr. Vice President
|
GrantCommon Stock | 1,645 | $2.23 | $3,668.35 |
DisclosureSEC source: 0001236215-17-000005 · primary_doc.xml · nonDerivative · entry 1 PRICHEP PATRICIA B · CIK 0001236215 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,483 Read SEC document |
| June 29, 2017 Filed Jun 30, 2017 20:50 UTC |
ZIMMERMAN DANIEL HSenior Vice President
|
GrantOptions · Derivative | 6,000 | $0.01 Strike: $1.87 | $60.00 |
DisclosureSEC source: 0001236031-17-000009 · primary_doc.xml · derivative · entry 1 ZIMMERMAN DANIEL H · CIK 0001236028 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,968 Underlying: Common Stock · 6,000 shares Expires 2027-06-28 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| June 22, 2017 Filed Jun 23, 2017 11:13 UTC |
KERSTEN GEERT RDirector · Chief Executive Officer
|
GrantSeries MM Warrants · Derivative | 147,929 | $0.01 Strike: $1.86 | $1,479.29 |
DisclosureSEC source: 0001236031-17-000005 · primary_doc.xml · derivative · entry 2 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 607,717 Underlying: Common Stock · 147,929 shares Expires 2022-06-22 Read SEC document |
| June 22, 2017 Filed Jun 23, 2017 11:13 UTC |
KERSTEN GEERT RDirector · Chief Executive Officer
|
GrantConvertible Note · Derivative | 147,929 | $250,000.00 Strike: $1.69 | $36,982,250,000.00 |
DisclosureSEC source: 0001236031-17-000005 · primary_doc.xml · derivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 459,788 Underlying: Common Stock · 147,929 shares Expires 2017-12-22 F1 · security: Mr. Kersten participated in an offering and purchased a note in the principal amount of $250,000. Shares issuable upon the conversion of the note will be restricted securities unless registered. Read SEC document |
| June 12, 2017 Filed Jun 30, 2017 20:43 UTC |
BAILLAVOINE BRUNO JEAN-MARIEDirector
|
GrantOptions · Derivative | 7,500 | $0.01 Strike: $2.50 | $75.00 |
DisclosureSEC source: 0001236031-17-000008 · primary_doc.xml · derivative · entry 1 BAILLAVOINE BRUNO JEAN-MARIE · CIK 0001646989 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 7,500 shares Expires 2027-06-11 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| June 12, 2017 Filed Jun 30, 2017 20:38 UTC |
ESTERHAZY ALEXANDER GDirector
|
GrantOptions · Derivative | 7,500 | $0.01 Strike: $2.50 | $75.00 |
DisclosureSEC source: 0001236031-17-000007 · primary_doc.xml · derivative · entry 1 ESTERHAZY ALEXANDER G · CIK 0001238026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,373 Underlying: Common Stock · 7,500 shares Expires 2027-06-11 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| June 12, 2017 Filed Jun 30, 2017 20:34 UTC |
YOUNG PETER RDirector
|
GrantOptions · Derivative | 7,500 | $0.01 Strike: $2.50 | $75.00 |
DisclosureSEC source: 0001236031-17-000006 · primary_doc.xml · derivative · entry 1 YOUNG PETER R · CIK 0001238029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,587 Underlying: Common Stock · 7,500 shares Expires 2027-06-11 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 14:10 UTC |
ZIMMERMAN DANIEL HSenior Vice President
|
GrantCommon Stock | 39,911 | $0.09 | $3,416.38 |
DisclosureSEC source: 0001236031-17-000004 · primary_doc.xml · nonDerivative · entry 1 ZIMMERMAN DANIEL H · CIK 0001236028 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,023 Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 14:06 UTC |
TALOR EYALChief Scientific Officer
|
GrantCommon Stock | 28,037 | $0.09 | $2,399.97 |
DisclosureSEC source: 0001236031-17-000003 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,306,368 Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 14:02 UTC |
PRICHEP PATRICIA BSenior Vice President
|
GrantCommon Stock | 42,869 | $0.09 | $3,669.59 |
DisclosureSEC source: 0001236031-17-000002 · primary_doc.xml · nonDerivative · entry 1 PRICHEP PATRICIA B · CIK 0001236215 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,395,947 Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 13:59 UTC |
KERSTEN GEERT RDirector · Chief Executive Officer
|
GrantCommn Stock | 46,436 | $0.09 | $3,974.92 |
DisclosureSEC source: 0001236031-17-000001 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,026,505 Read SEC document |
| December 30, 2016 Filed Jan 3, 2017 15:46 UTC |
ZIMMERMAN DANIEL HSr. Vice President
|
GrantCommon Stock | 46,026 | $0.07 | $3,083.74 |
DisclosureSEC source: 0001236215-17-000004 · primary_doc.xml · nonDerivative · entry 1 ZIMMERMAN DANIEL H · CIK 0001236028 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,112 Read SEC document |
| December 30, 2016 Filed Jan 3, 2017 15:30 UTC |
TALOR EYALChief Scientific Officer
|
GrantCommon Stock | 35,820 | $0.07 | $2,399.94 |
DisclosureSEC source: 0001236215-17-000003 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,278,331 Read SEC document |
| December 30, 2016 Filed Jan 3, 2017 15:13 UTC |
PRICHEP PATRICIA BSr. Vice President
|
GrantCommon Stock | 50,206 | $0.07 | $3,363.80 |
DisclosureSEC source: 0001236215-17-000002 · primary_doc.xml · nonDerivative · entry 1 PRICHEP PATRICIA B · CIK 0001236215 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,353,078 Read SEC document |
| December 30, 2016 Filed Jan 3, 2017 15:07 UTC |
KERSTEN GEERT RDirector · CEO
|
GrantCommon Stock | 59,328 | $0.07 | $3,974.98 |
DisclosureSEC source: 0001236215-17-000001 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,980,069 Read SEC document |
| September 30, 2016 Filed Oct 3, 2016 17:14 UTC |
ZIMMERMAN DANIEL HSenior Vice President
|
GrantCommon Stock | 11,388 | $0.30 | $3,416.40 |
DisclosureSEC source: 0001236031-16-000046 · primary_doc.xml · nonDerivative · entry 1 ZIMMERMAN DANIEL H · CIK 0001236028 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,086 Read SEC document |
| September 30, 2016 Filed Oct 3, 2016 17:11 UTC |
TALOR EYALChief Scientific Officer
|
GrantCommon Stock | 8,000 | $0.30 | $2,400.00 |
DisclosureSEC source: 0001236031-16-000045 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,242,511 Read SEC document |
| September 30, 2016 Filed Oct 3, 2016 17:08 UTC |
PRICHEP PATRICIA BSenior Vice President
|
GrantCommon Stock | 12,232 | $0.30 | $3,669.60 |
DisclosureSEC source: 0001236031-16-000044 · primary_doc.xml · nonDerivative · entry 1 PRICHEP PATRICIA B · CIK 0001236215 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,302,872 Read SEC document |
| September 30, 2016 Filed Oct 3, 2016 17:06 UTC |
KERSTEN GEERT RDirector · Chief Executive Officer
|
GrantCommon Stock | 13,250 | $0.30 | $3,975.00 |
DisclosureSEC source: 0001236031-16-000043 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,920,741 Read SEC document |
| August 31, 2016 Filed Sep 23, 2016 21:10 UTC |
DE CLARA MAXIMILIANFormer Officer and Director
|
GrantCommon Stock | 650,000 | $0.47 | $305,500.00 |
DisclosureSEC source: 0001236031-16-000042 · primary_doc.xml · nonDerivative · entry 1 DE CLARA MAXIMILIAN · CIK 0001236031 · Former Officer and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 675,123 F1 · shares: The first 325,000 shares will be issued promptly after August 31, 2016. Of the first 325,000 shares, none of the shares may be sold prior to February 28, 2017. Starting on February 28, 2017, each month the Company will remove the restrictive legend on 65,000 shares. F2 · shares: The second 325,000 shares will be issued on August 31, 2017, but may not be sold prior to February 28, 2018. Starting on February 28, 2018, each month the Company will remove the restrictive legend on 65,000 shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.